Related Experiment Video

Updated: Sep 20, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

546

Mucosal implications of oral Jak3-targeted drugs in COVID patients

Narendra Kumar1, Daniel Segovia2, Priyam Kumar3

  • 1ILR-College of Pharmacy, Texas A&M University Health Science Center, Kingsville, TX, USA. narendra08@tamu.edu.

Molecular Medicine (Cambridge, Mass.)
|May 23, 2025
PubMed

Insights

Janus kinase 3 (JAK3) inhibitors show promise for treating severe COVID-19 inflammation. However, their immunosuppressive effects necessitate careful patient selection and monitoring to mitigate risks of secondary infections and optimize therapeutic outcomes.

Area of Science:

  • Immunology
  • Pharmacology
  • Virology

Background:

  • Janus kinase 3 (JAK3) is vital for immune signaling and inflammatory responses.
  • Dysregulated JAK3 activation is linked to severe inflammation and respiratory issues in SARS-CoV-2 infections.
  • JAK inhibitors are explored as a therapeutic strategy for COVID-19.

Purpose of the Study:

  • To review the role of JAK3 in immune and epithelial cells.
  • To examine adverse effects of oral JAK3 inhibitors in COVID-19 and other conditions.
  • To discuss alternative strategies for optimizing JAK inhibitor therapy.

Main Methods:

  • Literature review of JAK3's role in immunity and inflammation.
  • Analysis of adverse effects of oral JAK3 inhibitors.
  • Exploration of alternative therapeutic approaches.

Main Results:

  • JAK3 plays a key role in immune and epithelial cell function.
  • Oral JAK3 inhibitors carry risks of immunosuppression and secondary infections.
  • Current strategies require careful patient selection and monitoring.

Conclusions:

  • JAK3 inhibition is a potential treatment for COVID-19-related inflammation.
  • Balancing efficacy with immunosuppression risks is critical.
  • Alternative strategies are needed to improve safety and outcomes.
Keywords:
Covid-19Jak3Keyword 1Keyword 2Keyword 3Mucosal -epithelial

More Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-308:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.2K
Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice08:02

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice

Published on: February 18, 2015

10.1K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
471
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
503
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
401